DSM-Firmenich
96,16 €Variazione rispetto alla chiusura precedente: +0,06%Variazione assoluta: +0,06 €
In sintesi
- Crescita dei ricavi
- −0,22%
- 2025 rispetto a 2024
- Margine netto
- -12,0%
- 2024: 2,8%
Dati finanziari
Importi in milioni di EUR; valori per azione in EUR; azioni in milioni.
| Voce | T2 2026 | T4 2025 | T2 2025 | T4 2024 | T2 2024 | T4 2023 | T2 2023 | T4 2022 | T2 2022 | T4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ricavi totali | 4.664 | — | 4.643 | — | 6.298 | — | 4.470 | — | 4.115 | — |
| Costo del venduto | 2.798 | — | 2.795 | — | 4.230 | — | 3.062 | — | 2.689 | — |
| Utile lordo | 1.866 | — | 1.848 | — | 2.068 | — | 1.408 | — | 1.426 | — |
| Reddito operativo | 370 | — | 383 | — | 157 | — | -371 | — | 398 | — |
| EBIT | 370 | — | 383 | — | 157 | — | -371 | — | 398 | — |
| EBITDA | 835 | — | 963 | — | 752 | — | 43,0 | — | 694 | — |
| Oneri finanziari | 66,0 | — | 69,0 | — | 46,0 | — | 77,0 | — | 39,0 | — |
| Utile ante imposte | 288 | — | 264 | — | 109 | — | -448 | — | 363 | — |
| Imposte | 63,0 | — | 67,0 | — | 59,0 | — | -36,0 | — | 72,0 | — |
| Utile netto | 212 | — | 510 | — | 42,0 | — | 2.367 | — | 450 | — |
| Utile netto per gli azionisti ordinari | 212 | — | 510 | — | 42,0 | — | 2.361 | — | 449 | — |
| EPS base | 0,85 | — | 1,94 | — | 0,16 | — | 11,77 | — | 2,60 | — |
| EPS diluito | 0,85 | — | 1,94 | — | 0,16 | — | 11,77 | — | 2,60 | — |
| Azioni medie (base) | 250 | — | 264 | — | 265 | — | 201 | — | 173 | — |
| Azioni medie (diluite) | 250 | — | 264 | — | 265 | — | 201 | — | 173 | — |
| Dividendo per azione | — | — | — | — | — | — | — | — | 0,93 | — |